Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In recognition of the new links with the Nuffield Department of Clinical Neurosciences and the Department of Experimental Psychology, the Oxford Clinical Trials Unit for Mental Illness (OCTUMI) has a new name: the Oxford Cognitive Health and Neuroscience Clinical Trials Unit (OCHNCTU, pronounced oc-n-tü) and a new logo.

The OCHNCTU portfolio will, in future, include trials for neurological conditions and cognitive neuroscience. The CTU offers advice and support in all aspects of the planning, conducting and reporting of clinical trials. Key areas of expertise include statistics, trial management, quality assurance, database provision and data management. Where resources permit, specific services (such as a randomisation program or trial monitoring) can be provided.

 

OCHNCTU projects include both non-commercial efficacy trials designed to reduce the uncertainties associated with current treatments and early phase trials evaluating potential new treatments. The CTU is working closely with the Oxford NHS Trusts to increase research productivity and recruitment into trials and has links with TVCLRN, DeNDRoN, the MHRN and other Oxford University Clinical Trials Units. OCHNCTU is also closely affiliated to the Oxford Cognitive Health Clinical Research Facility which supports the translation of neuroscience discoveries into effective therapies. 

For more information, contact Dr Jennifer Rendell on 01865 226465, email ochnctu@psych.ox.ac.uk

Similar stories

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.